SCHEMBL7216602

SCHEMBL7216602

CCOc1ccc(-c2nc3ccccn3c2-c2ccc(S(C)(=O)=O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.56
NR1I3 Q14994 1/20 0.52
AKT1 P31749 1/20 0.46
AKT2 P31751 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
PKM P14618 1/20 0.46
MAPK1 P28482 1/20 0.46
CDK19 Q9BWU1 1/20 0.45
ALK Q9UM73 1/20 0.45
KDM4E B2RXH2 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
USP7 Q93009 1/20 0.44
PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221860 0.87 PTGS2 (0.71) PTGS2NR1I3NPC1RAB9AALDH1A1
SCHEMBL7218055 0.86 PTGS2 (0.64) PTGS2NR1I3AKT1AKT2NPC1
SCHEMBL7217160 0.84 PTGS2 (0.56) PTGS2NR1I3AKT1AKT2NPC1
SCHEMBL7222132 0.83 PTGS2 (0.49) PTGS2AKT1AKT2NPC1RAB9A
SCHEMBL7214573 0.83 PTGS2 (0.51) PTGS2AKT1AKT2NPC1RAB9A
SCHEMBL7215987 0.83 PTGS2 (0.53) PTGS2NR1I3AKT1AKT2ALDH1A1
SCHEMBL7216221 0.83 PTGS2 (0.48) PTGS2AKT1AKT2SMN1; SMN2KDM4E
SCHEMBL8565114 0.82 PTGS2 (0.62) PTGS2NR1I3ALDH1A1KDM4EHDAC6
SCHEMBL7217081 0.82 PTGS2 (0.62) PTGS2NR1I3ALDH1A1KDM4EHDAC6
SCHEMBL7546647 0.78 PTGS2 (0.53) PTGS2NR1I3NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1104762-B1 SUBSTITUTED IMIDAZO[1,2A]AZINES AS SELECTIVE INHIBITORS OF COX-2 S A L V A T LAB SA (ES) 2002-09-18 EP claimed
EP-1104762-A1 SUBSTITUTED IMIDAZO 1,2A]AZINES AS SELECTIVE INHIBOTORS OF COX-2 LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2001-06-06 EP claimed
US-6670365-B1 Treatment of inflamation and/or cyclooxygenase-mediated diseases, reduced ulcerogenic effects; 2-phenyl-3-(4-methylsulfonylphenyl)imidazo(1,2-a)pyrimidine LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2003-12-30 US disclosed
EP-1104762-B1 SUBSTITUTED IMIDAZO[1,2A]AZINES AS SELECTIVE INHIBITORS OF COX-2 S A L V A T LAB SA (ES) 2002-09-18 EP disclosed
EP-1104762-A1 SUBSTITUTED IMIDAZO 1,2A]AZINES AS SELECTIVE INHIBOTORS OF COX-2 LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2001-06-06 EP disclosed